Galena Biopharma, Inc. (NASDAQ:GALE)

CAPS Rating: 1 out of 5

Results 1 - 10 of 10

Recs

0
Member Avatar clangmead (22.95) Submitted: 2/11/2016 9:34:54 AM : Outperform Start Price: $0.71 GALE Score: +6.70

mpor2

Recs

0
Member Avatar NHWeston102 (< 20) Submitted: 10/6/2015 10:43:34 AM : Underperform Start Price: $1.74 GALE Score: +49.37

Burning cash, having trouble borrowing, and not showing much results at a time when biotechs are in agony.

Recs

0
Member Avatar StarWitchDoctor (99.48) Submitted: 7/28/2015 4:11:17 PM : Underperform Start Price: $4.22 GALE Score: +81.69

cow me down

Recs

0
Member Avatar drugtrader (90.09) Submitted: 3/25/2015 12:31:39 AM : Outperform Start Price: $1.49 GALE Score: -37.11

2 thumbs up from zzporte! I wasn't sure which way to go thanks.

Recs

1
Member Avatar ruinas (25.75) Submitted: 12/27/2014 3:50:21 PM : Underperform Start Price: $1.53 GALE Score: +38.83

Markets overbought - correction due

Recs

0
Member Avatar bargain123 (24.54) Submitted: 12/26/2014 5:46:04 PM : Outperform Start Price: $1.53 GALE Score: -38.83

Technicals look good, product matured, this company will either make money on its own or been bought by Big Guy in this space

Recs

0
Member Avatar DougD720 (< 20) Submitted: 7/17/2014 11:05:35 AM : Outperform Start Price: $2.65 GALE Score: -64.98

Neuvax, highly undervalued due to scandal, still solid company with an excellent pipeline.

Recs

0
Member Avatar herbertslojewski (58.52) Submitted: 7/7/2014 3:56:58 PM : Outperform Start Price: $2.94 GALE Score: -68.19

Great new anti-cancer developments.

Recs

0
Member Avatar manirg (< 20) Submitted: 3/11/2014 9:48:12 AM : Outperform Start Price: $3.37 GALE Score: -76.03

highly undervalued, huge potential, has 2 drugs approved

Recs

0
Member Avatar jgvega (< 20) Submitted: 2/23/2014 3:58:40 PM : Outperform Start Price: $3.92 GALE Score: -81.11

Great chances of being revenue positive towards the end of the year thanks to drug Abstral. Huge market potential for breast cancer drug NueVax (if passed by FDA. it has great chances). Positive ratings from many analysts. Oh, and it’s undervalued due to recently ended bear raid. All and all, great stock and price with multi bagger potential for 2014. check it out.

Results 1 - 10 of 10

Featured Broker Partners